Date: September 14, 2023
Time: 12:00pm EST
Presenters:
Todd Wandstrat, PharmD, VP, Medical Affairs
Joseph Gomes, PharmD, MS, Director, Health Economics, MSL, LCDR, USN-ret, Past CAPT, US Public Health Service and SSGT, US Air National Guard
After attending the OLINVYK (oliceridine) educational session the participant will be able to:
1. Describe oliceridine’s hypothesized mechanism of action, pharmacokinetic and pharmacodynamic profile
2. List common opioid related adverse effects
3. Summarize phase 3 efficacy and safety data for the oliceridine clinical development program
4. Discuss clinical challenges in managing patients with opioid related adverse reactions
Virtual Platform: GoToWebinar
Target Audience: Surgeons, Anesthesiologists, CRNAs, PACU Nurses, and Pharmacists.
Fee: $0
CME/CE: 0 hrs
This webinar is sponsored by:
